journal of cancer research and therapeutics1970Vol. 16pp. -
236
d1970journaleffect
Abstract
This study suggests that HNSCC patients with Gln substitution in place of Arg at position 399 (both homozygous and heterozygous) in XRCC1 protein have significantly inferior survival functions, higher recurrence rate, and events after radical treatment.